Skip to main content
Caplight Logo









Pluton Biosciences

Pluton Biosciences

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://www.plutonbio.com/

Last Round

Series A

May 24, 2023

Total Funding Raised

$23.11M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Pluton Biosciences is a biotechnology company that leverages its Micromining platform to discover novel microbes for sustainable solutions in agriculture, such as crop protection and carbon sequestration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Carbon Capture, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

microbial discoverybiotech R&Dbio-pesticidesbio-fertilizersagtechmicrobiome researchcarbon sequestrationdrug discoverysynthetic biologysynbiohigh-throughput screeningmicrobial consortiaAI-enabled discoverybiological alternativesagrobiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pluton Biosciences Comparables

Compare Pluton Biosciences with similar companies based on industry and business-model similarity.

Pluton Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Concerto Biosciences
86%
BioConsortia, Inc.
82%
Boost Biomes
78%

Pluton Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 24, 2023
SeedOct 5, 2021

Key People

Founding team and executive leadership

Elizabeth Gallegos

Chief Executive Officer, Chief Financial Officer

Executive Team

Pluton Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 150% MoM.

  • Aug 1, 2026

    Open roles increased to 7, representing 26% of headcount.

Pluton Biosciences Filings

Explore SEC and related filing metadata, where available.

Pluton Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pluton Biosciences's valuation, stock price, and market status.

Is Pluton Biosciences a public or private company?

Pluton Biosciences is a private company.

What is the current stock price of Pluton Biosciences?

Pluton Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Pluton Biosciences worth (valuation)?

Valuation information for Pluton Biosciences is not publicly available.

Can I buy Pluton Biosciences stock?

Pluton Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pluton Biosciences's last funding round?

Pluton Biosciences's most recent funding round was Series A on May 24, 2023.

Who are the main investors in Pluton Biosciences?

Key investors in Pluton Biosciences include Better Ventures, RA Capital Management, Illumina Ventures.

Will Pluton Biosciences IPO soon?

No public IPO plans have been announced for Pluton Biosciences.

How can I track Pluton Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pluton Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range23
Year Founded2017
Last FundingMay 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?